Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
Wireless technologies for isolated rural communities in developing countries based on cellular 3G femtocell deployments (TUCAN3G)

Framework: FP7 — Cooperation
Programme: Information and Communication Technologies
Destination: International Cooperation
Action type: Collaborative project
Countries involved: Spain,Spain,Peru,Colombia,United Kingdom,Greece
Call:  (FP7-ICT-2011-9, 2011)
Start date: 2013-02-01
End date: 2016-05-31
Duration (months): 40.0
Total project cost (EUR): 1365123.0
EU funding (EUR): 1016000.0
Participants: 11
Project status: CLOSED

TUCAN3G is built upon the basic premise that considers information and communications as a key factor of human development. The diffusion of ICT in developing countries has been very asymmetric between densely populated urban areas and isolated rural areas. Geographical conditions have often conditioned solutions for Internet connectivity in rural areas, often based on wireless 2G cellular technologies. From a technological and socio-economical), this project proposes to study the introduction of 3G Femtocells (and its evolution to 4G) in outdoor environments, with backhauling heterogeneous WiLD (WiFi for Long Distances) - WiMAX - VSAT, to provide access to voice and data services to remote rural areas in developing countries. More specifically, the project aims to three specific objectives framed in: (SO1) technology development, (SO2) market research and elaboration of business models, and (SO3) in verification through proofs of concept in platforms installed in basins of the rivers Napo and Putumayo (Peru), which will allow deploying several femtocells in 4 remote rural locations. The technological objective (SO1) aims at optimizing access networks FWI (Femto-WiFi Integration) and heterogeneous transport networks WWVI (WiLD-WiMAX Integration VSAT) to provide 3G service to isolated rural populations in a progressive way . This objective will adopt interference management solutions studied in the ICT project FREEDOM (www.ict-freedom.eu) for the outdoor rural scenario and will introduce LIPA (IP Local Access) and SIPTO (Selected IP Traffic Offload) features to reduce the burden on the transport network. On its turn, optimal solutions for resource allocation and flow control for WiLD transport networks (WiFi parameterization for long distance and quality of service management) and VSAT (hard & soft acceleration) will be derived. In all cases we will consider the critical factors associated to the energy consumption.

Keywords: rural wireless communication,femtocell networks,business case study,wifi-based and vsat-based transport networks,green comm.,self-organizing networks,demonstration platforms,standardization
WEARable HAPtics for Humans and Robots (WEARHAP)

Framework: FP7 — Cooperation
Programme: Information and Communication Technologies
Destination: Cognitive Systems and Robotics
Action type: Collaborative project
Countries involved: Italy,Germany,Germany,Greece,Spain,Italy,France,Sweden
Call:  (FP7-ICT-2011-9, 2011)
Start date: 2013-03-01
End date: 2017-08-31
Duration (months): 54.0
Total project cost (EUR): 10040081.0
EU funding (EUR): 7700000.0
Participants: 11
Project status: CLOSED

The complexity of the world around us is creating a demand for cognition-enabled interfaces that will simplify and enhance the way we interact with the environment. The recently unveiled project Glass by Google is a case that seeks to address this demand for the sense of vision. Project WEARHAP, developed in this proposal, aims at laying the scientific and technological foundations for wearable haptics, a novel concept for the systematic exploration of haptics in advanced cognitive systems and robotics that will redefine the way humans will cooperate with robots. The challenge of this new paradigm stems from the need for wearability which is a key element for natural interaction. This paradigm shift will enable novel forms of human intention recognition through haptic signals and novel forms of communication and cooperation between humans and robots. Wearable haptics will enable robots to observe humans during natural interaction with their shared environment. Research challenges are ambitious and cross traditional boundaries between robotics, cognitive science and neuroscience. Research findings derived from distributed robotics, biomechanical modeling, multisensory tracking, underaction in control and cognitive systems will be integrated to address the scientific and technological challenges imposed in creating effective wearable haptic interaction. To highlight the enabling nature, the versatility and the potential for industrial exploitation of WEARHAP, the research challenges will be guided by representative application scenarios. These applications cover robotics, health and social scenarios, stretching from human-robot interaction and cooperation for search and rescue, to human-human communication, and interaction with virtual worlds through interactive games.

Keywords: haptics cognitive control wearable technology human-robot cooperation multi dof systems intention recognition multisensor fusion markerless hand tracking bio-signal processing
Convergence Science Network of Biomimetics and NeuroTechnology (CSNII)

Framework: FP7 — Cooperation
Programme: Information and Communication Technologies
Destination: Future and Emerging Technologies
Action type: Coordination and support actions
Countries involved: Spain,United Kingdom,Italy,Switzerland,Japan,United States
Call:  (FP7-ICT-2011-9, 2011)
Start date: 2013-03-01
End date: 2016-02-29
Duration (months): 36.0
Total project cost (EUR): 1064936.0
EU funding (EUR): 950000.0
Participants: 6
Project status: CLOSED

Despite tremendous progress in neuroscience, ICT and related fields we are still unable to build perceptive, emotive and cognitive systems that are comparable with even simple insect brains with respect to function, energy sufficiency or computational power. One promising approach to answer this challenge is to translate principles underlying the abilities of natural systems into new technologies. Such an advance would entail major societal and economical impacts, particularly in the areas of information and communication technologies, robotics, brain-machine interfacing, quality of life and health and nanotechnology applied to life sciences. In parallel this paradigm would boost our fundamental understanding of mind and brain: ourselves. Currently the fields of research in Neuro- and Bio-inspired Systems (NBIS) on which these developments depend are critically fragmented, lacking common objectives, methods, critical mass and penetration of the academic curricula with associated obstacles for growth and consolidation. The Coordination Action Convergent Science Network for Biomimetics and Neurotechnology (CSNII) will directly address these challenges. CSNII will advance the definition, visibility, federation and consolidation of research in the Future and Emerging Technology area of NBIS with specific emphasis on Biomimetics and Neurotechnology. CSNII will achieve these objectives by advancing and developing strategic roadmaps, supporting workshops, the annual conference “Living Machines” and realizing global cooperation and alliances in particular through collaborations with similar and well established activities in the USA and Japan. At the end of this 3 year project we expect a measurable impact on the level of collaboration and the quality of research in Biomimetics and Neurotechnology combined with a direct impact on post graduate curricula and funding policies and mechanisms furthering this strategic field in which Europe can obtain international leadership.

Keywords: biomimethics,neurotechnology,neuro-bio-inspired systems,neuromorphic,neuroprosthetics,neurorobotics
Reusable low-cost platform for digitizing and preserving traditional participative sports (REPLAY)

Framework: FP7 — Cooperation
Programme: Information and Communication Technologies
Destination: ICT for Learning and Access to Cultural Resources
Action type: Collaborative project
Countries involved: Spain,Ireland,Switzerland,United Kingdom,Greece,Spain,United Kingdom
Call:  (FP7-ICT-2011-9, 2011)
Start date: 2013-03-01
End date: 2016-02-29
Duration (months): 36.0
Total project cost (EUR): 2575271.0
EU funding (EUR): 1949637.0
Participants: 8
Project status: CLOSED

Sport is the most universal and accessible of cultural pursuits. European Traditional Sports and Games (TSG) are as diverse as our cultures. TSG organisations work tirelessly to promote participation in their sports, but also as custodians of custom, language and history. The TSG club or playing field is often the focal point of community life. Trends in globalisation have led to a convergence of spectator interest to just a few mainstream sports with culturally homogonous identities. Re-Play will focus on two families of TSG (Gaelic and Basque), that are integral to the fabric of their communities of origin and have successfully staved off this trend of convergence. Gaelic and Basque sports are also practiced internationally and experience high levels of participation amongst all genders and age groups. They also share common techniques and forms of play and thus, open the opportunity for the Re-Play project results to be applied to other TSGs. To this end Re-Play will include an advisory group of other TSG associations and its results will be made available under Open Source or Hybrid license models. Re-Play proposes a study of the biomechanics and play dynamics of a number of sports and the creation of capture methodologies which balance cost and effectiveness. The platform will use off-the shelf and sensors and leading-edge studio rigs. Such an approach will allow the styles of play of elite sportspersons (national heroes) to be captured with precision for posterity, and amateur sportspersons (local heroes) for the more routine elements of play with inexpensive setups as well as a comparison of the two approaches. Re-Play includes novel 3D rendering and interaction for coaching, teaching and entertainment to allow a user practice new basic skills and to emulate their hero. A video only approach is included to recover techniques of past players from legacy video content, thus allowing for an analysis of the evolution of the sport into the future.

Keywords: motion capture,sport,traditional sport,gaelic games,basque pelota,biomechanics
A Guided Matter-Wave Interferometer on a Atom-Chip (MATTERWAVE)

Framework: FP7 — Cooperation
Programme: Information and Communication Technologies
Destination: Future and Emerging Technologies
Action type: Collaborative project
Countries involved: Greece,United Kingdom,Israel,Italy,United Kingdom
Call:  (FP7-ICT-2011-9, 2011)
Start date: 2013-02-01
End date: 2017-07-31
Duration (months): 54.0
Total project cost (EUR): 3435493.0
EU funding (EUR): 2600000.0
Participants: 5
Project status: CLOSED

The ultimate aim of the proposed research is to make ultra-sensitive matter-interferometry available in a compact and eventually portable device. Specifically, we seek to test the ideas in a guided matter-wave interferometer based on ultracold bosonic atoms. We will explore matter-wave interferometry in macroscopic traps as well as on atom-chips. Such device has the potential to induce a step change in the sensitivity with which acceleration and rotation can be measured. The expected impact extends well beyond fundamental research, for example to geoscience and navigation. En route to the ultimate goal of a portable matter-wave interferometer, we hope to break new ground in the understanding of important aspects of matter-wave interferometry with interacting atomic gases. We will strive to master the coherence preserving manipulation of matter-waves in wave-guides and the miniaturisation eventually down to the size of a microchip. In addition, we will address the challenge of combining all these ingredients in a mobile device.
Emulating the C. elegans nervous system: A blueprint for brain-inspired computational architectures (SI ELEGANS)

Framework: FP7 — Cooperation
Programme: Information and Communication Technologies
Destination: Future and Emerging Technologies
Action type: Collaborative project
Countries involved: Italy,United Kingdom,Spain,Ireland,United Kingdom
Call:  (FP7-ICT-2011-9, 2011)
Start date: 2013-04-01
End date: 2016-09-30
Duration (months): 42.0
Total project cost (EUR): 3570605.0
EU funding (EUR): 2727000.0
Participants: 5
Project status: CLOSED

Biological neural systems are powerful, robust and highly adaptive computational entities that outperform conventional computers in almost all aspects of sensory-motor integration. Despite dramatic progress in information technology, there is a big performance discrepancy between artificial systems and brains in seemingly simple orientation and navigation tasks. In fact, no system exists that can faithfully reproduce the rich behavioural repertoire of the tiny worm Caenorhabditis elegans which features one of the simplest nervous systems in nature made of 302 neurons and about 8000 connections. Si elegans aims at providing this missing link. We propose to develop a computing framework that accurately mimics C. elegans and let complex and realistic behaviour emerge through its interaction with a rich, dynamic simulation of a natural environment. We will replicate the nervous system of C. elegans on a highly parallel, modular, arbitrarily programmable, reconfigurable and scalable hardware architecture, virtually embody it for behavioural studies in a realistic virtual environment and provide the resulting computational platform through an open-access web portal to the scientific community for its peer-validation and use. Si elegans will constitute a generalizable framework from which the universal working principles of nervous system function can be induced, and new scientific knowledge on higher brain function and behaviour can be generated. More importantly, it will lay the foundation for exploring and refining new neuromimetic computational concepts and will provide a blueprint for the design of brain-like hardware architectures that are orthogonal to current von Neumann-type machines. The 3-year project brings together a highly interdisciplinary, experienced and focused research team from leading European institutions with well-balanced complementary skills and will reach out to the world-wide scientific community in a peer-contribution and validation approach.

Keywords: neuro-bio-inspired systems,neuromimetic computation,c. elegans,nervous system emulation,neural circuits and assemblies,neural coding,optical computing,physics-based simulation,peer-contribution
A new therapeutic antibody with a personalised medicine approach in cardiovascular disease (CARDIMMUN)

Framework: FP7 — Cooperation
Programme: Health
Destination: Horizontal topics for collaborative projects relevant for the whole of theme health
Action type: Collaborative project
Countries involved: Netherlands,Finland,Norway,Sweden,Sweden
Call:  (FP7-HEALTH-2013-INNOVATION-2, 2013)
Start date: 2013-08-01
End date: 2016-07-31
Duration (months): 36.0
Total project cost (EUR): 7785840.0
EU funding (EUR): 5995080.0
Participants: 5
Project status: CLOSED

The project, CARDIMMUN, aims to pursue development of the scientific findings from the FP6 project CVDImmune. Based on our patented discovery, that low levels of anti-PC (phosphorylcholine) indicate risk for future development of cardiovascular disease, we have developed both a diagnostic test (a marker to identify cardiovascular disease patients that are at high risk of secondary events) and a candidate drug - an innovative fully human monoclonal antibody antibody, PC-mAb - that can block vascular inflammation. Together, this forms a unique opportunity for a personalised medicine approach, with a companion diagnostic and a targeted intervention in an area that is still in great medical need, despite recent advances in therapy. PC-mAb is now ready for clinical development. The project will be progressed, by a structured plan that brings together SMEs and selected academic partners, and integrates preclinical and clinical studies into a commercially viable and mature therapeutic modality. The 5 work packages will embrace concept testing in animal models using biomarkers applicable also in human disease, coronary flow reserve and glucose uptake in inflamed arteries, as well as required toxicity studies. Additionally, studies in man are planned that explores safety, pharmacokinetics, pharmacodynamics and indices of clinical efficacy, including a placebo-controlled Proof of Activity trial in patients. Athera’s PC-mAb is targeting the market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. According to plan, the data will enable a business agreement with Athera and a partner (probably big pharma) to enter into larger scale clinical trials by early 2017. PC-mAb could then be launched on the market as a new drug, with clear block-buster potential, by year 2020.

Keywords: immunotherapy,personalised medicine,clinical trial
bioREACtor for stem cell tHerapy (REACH)

Framework: FP7 — Cooperation
Programme: Health
Destination: Horizontal topics for collaborative projects relevant for the whole of theme health
Action type: Collaborative project
Countries involved: Netherlands,Germany,Netherlands,United Kingdom
Call:  (FP7-HEALTH-2013-INNOVATION-2, 2013)
Start date: 2013-07-01
End date: 2016-06-30
Duration (months): 36.0
Total project cost (EUR): 6790994.76
EU funding (EUR): 5012127.02
Participants: 4
Project status: CLOSED

The REACH-project is a direct result of the FP7 StemExpand project, which aimed at the expansion and engraftment of hematopoietic and mesenchymal stem cells (MSC) for clinical use. The results of these research activities show that a novel, closed and controlled bioreactor can be developed to grow clinically relevant numbers (>400 million) of MSCs. XPand Biotechnology BV(NL) [bioreactor development, technology valorization], Aber Instruments ltd (UK)[biomass sensor] and PreSens Precision Sensing GmbH (GE) [DO, pH sensor] are three SMEs that have teamed up to develop this novel bioreactor system to a pre-commercial scale. The overall aim of the REACH project is to further develop and engineer the bioreactor (incl. valorization, testing and technical and biological validation) to a closed-system sensor-controlled bioreactor with sampling possibilities that allows for GMP-grade MSC production outside a cleanroom. The system will contain a disposable bioreactor bag with unique miniaturized disposable sensors. The DO and pH sensors use optical chemical methods capable of high frequency sampling, this ensures an enhanced stability of the expansion process. Using an expandable bioreactor the volume can be increased during cell culture, without the need for passaging of the cells. Because of this feature the system can be truly closed, without the limitations of a fixed culture substrate area. Leiden University Medical Center (NL) will validate the system and the products in a clinical setting by comparing bioreactor-expanded MSCs with GMP grade MSCs produced by established protocols in the LUMC. Successful development of this bioreactor system will be beneficial for the participating SMEs as well as the medical sector which will be able to develop cell therapies in a faster, cheaper and more efficient way. Collectively, the partners in REACH will develop an exploitation and business plan for the successful valorization of the research done in the FP7 StemExpand project.

Keywords: bioreactor,sensor,cell therapy,stem cell expansion,regenerative medicine,gmp manufacturing
Translation of novel Biomarkers for Bladder Cancer for clinical outcome prediction (TRANSBIOBC)

Framework: FP7 — Cooperation
Programme: Health
Destination: Horizontal topics for collaborative projects relevant for the whole of theme health
Action type: Collaborative project
Countries involved: Greece,Germany,Switzerland,Spain
Call:  (FP7-HEALTH-2013-INNOVATION-2, 2013)
Start date: 2013-09-01
End date: 2016-08-31
Duration (months): 36.0
Total project cost (EUR): 4181538.8
EU funding (EUR): 3260358.6
Participants: 4
Project status: CLOSED

Currently, clinical diagnosis and monitoring of bladder cancer (BC) relies on invasive, highly costly cystoscopy. Additionally, due to high recurrence rates BC treatment is associated with frequent follow-up of patients, making BC one of the most costly types of cancer in terms of management cost. Thus there is a clear clinical need for the development of new approaches for early detection of recurrence and progression. Our proposal is based on the identification of novel biomarkers (BM) for BC recurrence and progression in urine and powerful technological platforms as extensive foreground work of the involved partners in the framework of FP7 EU projects DECanBio and GENINCA. The objective of TransBioBC is to translate this foreground work in the field of BC and to specifically employ the involved technologies (CE-MS and micro-ELISA), represented by the participating SMEs, for the development of non-invasive urine tests for routine monitoring of BC recurrence and progression. Our project uniquely integrates leading BC clinical experts with experts on proteome analysis and high throughput immunoassay development in an implementation-oriented workflow. Strict monitoring of assay analytical performance, and properly collected and well characterized clinical samples from existing sufficiently powered BC cohorts are combined with in-depth knowledge of regulatory requirements, analysis approaches to define added value and well designed business plans including multi-stakeholder dissemination and exploitation plans. Collectively, TransBioBC will provide strong evidence for utility of the new BM directly in BC clinical management and as a secondary aim for usage in clinical trials and drug development.